Belgium Suspends J&J Vaccine
The Johnson & Johnson COVID-19 vaccine has been suspended in Belgium for individuals under the age of 41 after the first reported death in the European Union linked to severe side effects associated with the shot. The European Medicines Agency (EMA) is currently...
Peace Engine Kyoto Granted cGMP Compliant by Third-Party Certification
Peace Engine Kyoto was granted U.S. cGMP (Current Good Manufacturing Practices) by a third-party certification for its manufacturing facility in Kyoto, Japan. Previously awarded a permit in 2020 by Japan's Ministry of Health, Labour, and Welfare for manufacturing...
COVID-19 Vaccine of CanSinoBIO Receives European GMP
CanSinoBIO announced today that the Hungarian National Institute of Pharmacy and Nutrition (OGYÉI) has granted Good Manufacturing Practices (GMP) certification for its COVID-19 vaccine, Convidecia™. Dr. Xuefeng YU, Chairman and Chief Executive Officer of CanSinoBIO,...
FDA Clears Overjet’s AI Dental Assist
The U.S. Food and Drug Administration (FDA) has cleared Overjet's AI Dental Assist product, marking it the first AI technology to enter the dental industry to aid dental hygienists and dentists in real time. The SaMD (Software as a Medical Device) will support the...
Telehealth & Mental Health: COVID-19’s Impact for Global Well-being
Since the COVID-19 outbreak in 2020, there has been a significant rise in cases of mental health issues like stress, depression, and anxiety around the world. In addition to the anxiety surrounding the virus, disruptions in daily lifestyles globally have brought...
FDA Encourages Telemedicine For Gaps in Gene Therapy Trials
The U.S. Food and Drug Administration (FDA) is encouraging sponsors involved in gene therapy trials to fill data gaps with remote visits and telemedicine. The encouragement comes from Wilson Bryan, the FDA’s OTAT (Office of Tissues and Advanced Therapies) during the...
FDA Authorizes Roche for Testing COVID-19 Asymptomatic Individuals
The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Roche for its cobas® SARS-CoV-2 Test. The cobas® SARS-CoV-2 Test is designed to test asymptomatic individuals suspected to have COVID-19. The Center for Disease Control (CDC)...
ImmunityBio Receives FDA Authorization for Clinical Study of Memory Cytokine-Enriched NK Cell (m-ceNK) Platform in Solid Tumors
The U.S. Food and Drug Administration (FDA) authorized ImmunityBio Phase I clinical study for patients with metastatic or locally advanced solid tumors. The study will assess the safety and efficacy of ImmunityBio's IL-15 superagonist Anktiva (N-803) in combination...
Industry-First At-Home HPV Screening Has Been CE Marked
BD (Becton, Dickinson, and Company) announced today the first self-collection, at-home HPV screening has been CE marked to the IVD directive 98/79/EC. With this new claim, diagnostic labs will now be able to process the self-collected vaginal samples using the BD...
FDA Grants IDE to ZOLL Medical for ISO Shock Study
The U.S. Food and Drug Administration (FDA) has granted ZOLL Medical investigational device exemption (IDE) for a randomized study to evaluate TherOx® SuperSaturated Oxygen (SSO2) Therapy in patients with cardiogenic shock and ST Elevation Myocardial Infarction...
New Contact Lenses for Children to Slow Myopia Progression
Eyepic Eye Care announced a revolutionary service using the only FDA-approved MiSight multifocal contact lenses meant to slow myopia progression in children. Myopia, which is a refractive eye condition causing nearsightedness, affects approximately 40% of Americans...
Pfizer & BioNTech COVID-19 Vaccine Receives EUA for Young Teens
The U.S. Food and Drug Administration (FDA) expanded the emergency use authorization (EUA) for the Pfizer and BioNTech COVID-19 vaccine to now include young teens between 12 and 15 years of age. Previously, the EUA was approved for patients 16 years of age and older,...
FDA Clears ConforMIS, Inc.’s Knee Replacement System
The U.S. Food and Drug Administration (FDA) has granted ConforMIS Inc. 510(k) clearance for its Identity Imprint™ Knee Replacement System. Available in both posterior stabilized (PS) and cruciate retaining (CR) versions, the system expands the range of options for...
NMPA Approves PARP Inhibitor Pamiparib of BeiGene
China's regulatory body, the National Medical Products Administration (NMPA), has granted conditional approval to BeiGene's PARP inhibitor pamiparib for treatment of patients advanced ovarian cancer. The approval marks the first for pamiparib and the third for...
FDA Approves Viome’s mRNA Technology and AI Platform for Detecting Cancer
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the early detection of oral and throat cancer through their proprietary mRNA technology in combination with Viome's next-gen AI platform. The first-of-its-kind tool screens...
Pfizer & BioNTech COVID-19 Vaccine Expected Approval From FDA for Younger Teens
Pfizer & BioNTech's COVID-19 vaccine is expected to receive FDA approval for adolescents ages 12 and older sometime this week. The expected approval comes from a Phase III trial in adolescents between the ages of 12 and 15 with 2,260 participants that demonstrated...
U.S. Patent Granted to Kemin Industries for Treatment of Human Immune Function
Kemin Industries has announced that the U.S. Patent and Trademark Office has granted the US 10,912,794 patent on the beta 1, 3 glucan for treating inflammation in the intestine and modulating human immune function. The patent approval comes after the US 9,574,217...
FDA Approves Chiesi Global Rare Diseases’ Ferriprox for Sickle Cell Disease
The U.S. Food and Drug Administration (FDA) approved Chiesi Global Rare Diseases' Ferriprox for treating transfusional iron overload which is caused by sickle cell disease (SCD). The treatment is approved in patients three years old and older, and expands the drug use...
In Vitro Diagnostic Medical Devices Regulation (IVDR) 2017/746: Five key questions answered for MedTech Companies
It has been almost four years since the European Commission passed the In Vitro Diagnostic Medical Devices Regulation (IVDR) 2017/746 on May 26, 2017. With the new regulation set to be implemented in 2022, medical device manufacturers looking to market their products...
Alzheimer’s Drug Shows Language Improvement for Fragile X Syndrome
A new study published in the Nature Medicine journal has shown that Tetra Therapeutics' Alzheimer's investigational disease drug improves language and learning ability in adults diagnosed with Fragile X Syndrome. Fragile X Syndrome is a genetic condition that causes...